Skip to main content

Regeneron Pharmaceuticals Net product sales

  • REGN · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$955.47+0.45%Close 13 Nov 2026 · Market value $102.5B

Net product sales at Regeneron Pharmaceuticals came to $1.8B for the quarter to 30 Sep 2026, up 13.7% from a year earlier.

As Regeneron Pharmaceuticals reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$1.9BDec 2023$1.8BMar 2024$1.9BJun 2024$1.9BSep 2024$2.0BDec 2024$1.4BMar 2025$1.6BJun 2025$1.6BSep 2025$1.7BDec 2025$1.5BMar 2026$1.6BJun 2026$1.8BSep 2026
Regeneron Pharmaceuticals Net product sales, every reported period
Period endingNet product salesChange on a yearFiled
30 Sep 2026$1.8Bup 13.7%30 Oct 2026
30 Jun 2026$1.6Bup 0.7%30 Jul 2026
31 Mar 2026$1.5Bup 8.4%29 Apr 2026
31 Dec 2025$1.7Bdown 16.4%4 Feb 2026
30 Sep 2025$1.6Bdown 18.4%28 Oct 2025
30 Jun 2025$1.6Bdown 15.0%1 Aug 2025
31 Mar 2025$1.4Bdown 19.6%29 Apr 2025
31 Dec 2024$2.0Bup 8.2%5 Feb 2025
30 Sep 2024$1.9Bup 9.0%31 Oct 2024
30 Jun 2024$1.9Bup 8.3%1 Aug 2024
31 Mar 2024$1.8Bup 5.6%2 May 2024
31 Dec 2023$1.9Bup 9.0%5 Feb 2024
30 Sep 2023$1.8Bdown 0.8%2 Nov 2023
30 Jun 2023$1.8Bup 1.0%3 Aug 2023
31 Mar 2023$1.7Bup 1.8%4 May 2023
31 Dec 2022$1.7Bdown 57.3%6 Feb 2023
30 Sep 2022$1.8Bdown 21.0%3 Nov 2022
30 Jun 2022$1.8Bdown 57.6%3 Aug 2022
31 Mar 2022$1.6Bdown 5.0%4 May 2022
31 Dec 2021$4.0Bup 145.1%7 Feb 2022
30 Sep 2021$2.3Bup 53.8%4 Nov 2021
30 Jun 2021$4.1Bup 237.3%5 Aug 2021
31 Mar 2021$1.7Bup 39.4%6 May 2021
31 Dec 2020$1.6Bup 26.1%8 Feb 2021
30 Sep 2020$1.5Bup 19.7%5 Nov 2020
30 Jun 2020$1.2Bup 1.8%5 Aug 2020
31 Mar 2020$1.2Bup 12.0%5 May 2020
31 Dec 2019$1.3Bup 17.3%7 Feb 2020
30 Sep 2019$1.2Bup 20.8%5 Nov 2019
30 Jun 2019$1.2Bup 21.0%6 Aug 2019
31 Mar 2019$1.1Bup 11.8%7 May 2019
31 Dec 2018$1.1B—7 Feb 2019
30 Sep 2018$1.0Bup 7.1%6 Nov 2018
30 Jun 2018$996.4Mup 7.8%2 Aug 2018
31 Mar 2018$987.9M—3 May 2018
30 Sep 2017$957.4M—8 Nov 2017
30 Jun 2017$924.1M—3 Aug 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Regeneron Pharmaceuticals: Collaboration revenue · Libtayo revenue · Lynozyfic revenue · EYLEA HD And EYLEA revenue · EYLEA HD revenue · EYLEA revenue · Praluent revenue · Evkeeza revenue · financial statements

Every KPI and segment of REGN, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.